Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-03-04

Clinical Trial Update: Observational Study on Anti-Tat Immune Response in HIV-1-infected HAART-treated Adult Subjects

View source ↗

Summary

Observational study assessing anti-Tat immune responses in HIV-1-infected adults on HAART.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Barbara Ensoli, MD | Conditions: HIV Infection | Status: COMPLETED